Interleukin6 in COVID19: a systematic review and meta‐analysis

EA Coomes, H Haghbayan - Reviews in medical virology, 2020 - Wiley Online Library
… suggested that interleukin-6 (IL-6) levels are elevated in cases of complicated Covid-19, we
… investigating the immunological response in Covid-19; additional grey literature searches …

[HTML][HTML] Interleukin-6 as a potential biomarker of COVID-19 progression

ZS Ulhaq, GV Soraya - Medecine et maladies infectieuses, 2020 - ncbi.nlm.nih.gov
… IL-6 levels, or did not classify the condition of COVID-19 … , [2], [3], [4], [5], [6], [7], [8], [9].
Although the heterogeneity was … IL-6 levels were significantly increased in COVID-19-infected …

[HTML][HTML] Elevated interleukin6 and severe COVID19: a meta‐analysis

M Aziz, R Fatima, R Assaly - Journal of medical virology, 2020 - ncbi.nlm.nih.gov
… Based on our results, IL‐6 is an important marker of inflammation and … COVID19 early in
the disease course. Furthermore, researchers should develop a scoring system including IL‐6

Interleukin-6 as prognosticator in patients with COVID-19

E Grifoni, A Valoriani, F Cei, R Lamanna… - Journal of …, 2020 - journalofinfection.com
… In conclusion, in our COVID-19 population, IL-6 levels at hospital admission seem to be a
good prognosticator for the combined endpoint progression to severe disease and/or in-…

Assessing the importance of interleukin-6 in COVID-19

LYC Chen, RL Hoiland, S Stukas… - The Lancet …, 2021 - thelancet.com
… However, direct systematic comparisons of COVID-19 with other … of COVID-19 studies
published or posted as preprints between Nov 1, 2019, and April 14, 2020, in which interleukin-6

[HTML][HTML] Elevated interleukin6 is associated with severity of COVID19: a meta‐analysis

J Zhu, J Pang, P Ji, Z Zhong, H Li, B Li… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
… Our results are consistent with the idea that IL‐6 levels positively correlate with COVID19
IL‐6 are associated with severity of COVID19. And thus, monitoring IL‐6 levels in COVID19

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

B Liu, M Li, Z Zhou, X Guan, Y Xiang - Journal of autoimmunity, 2020 - Elsevier
… There is an urgent need for novel therapies to treat COVID-19-… CRS, compare the CRS in
COVID-19 with that in SARS and … to utilize interleukin-6 (IL-6) blockade to manage COVID-19-…

Interleukin-6 perpetrator of the COVID-19 cytokine storm

J Shekhawat, K Gauba, S Gupta, P Purohit… - Indian Journal of Clinical …, 2021 - Springer
… In this review, the pivotal role played by IL-6 in the immuno-pathology of COVID-19 has
been illustrated. The role of IL-6 as a pleiotropic cytokine executing both pro and anti-…

Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome

LYC Chen, RL Hoiland, S Stukas… - European …, 2020 - Eur Respiratory Soc
… of COVID-19 in our own centre, when IL-6 was being measured for research purposes rather
than clinical care, we used the following criteria for COVID-CSS: 1) COVID-19 pneumonia …

Interleukin-6 receptor antagonists in critically ill patients with Covid-19

Remap-Cap Investigators - New England Journal of Medicine, 2021 - Mass Medical Soc
… with Covid-19 showed that genetic variants in the interleukin-6interleukin-6 pathways in
patients with severe Covid-19. … trials of interleukin-6 receptor antagonists in Covid-19. Many …